Abstract:ObjectiveTo assess the correlation between Z‐scores of positive NIPT results and the positive predictive value (PPV) of non‐invasive prenatal testing (NIPT). MethodsPregnancies with positive NIPT results at Guangzhou Women and Children's Medical Centre between July 2017 and May 2020 were included in this study. Fetal karyotyping or microarray analysis was provided to patients with abnormal NIPT results for confirmatory testing. Logistic regression analyses was applied to study the relationship between the Z scores and the PPV performance. The optimal cut‐off values for indicating fetal common trisomies were obtained based on receiver operating characteristic (ROC) curve analysis, and then the PPV were calculated in pregnancies with positive NIPT results at Z‐score greater than or equal to cut‐off value and in patients with a Z‐score between 3 and cut‐off value respectively. ResultsA total of 214 pregnancies with positive NIPT results for fetal common trisomies were validated by invasive prenatal diagnosis and follow up in this study. Of these, NIPT indicated trisomy 13 in 25 cases, trisomy 18 in 54 cases and trisomy 21 in 135 patients. Logistic regression analyses showed a significant association (P<0.05) between the Z‐scores and true positive results for T21 and T18. For T13, the significant association was not observed (P>0.05). The ROC curve analysis showed that the optimal cut‐off Z‐score for indicating fetal trisomies 13, 18 and 21 were 6.889, 7.574 and 6.612 respectively, and the corresponding area under curve were 0.706, 0.916 and 0.954. In this cohort with abnormal NIPT results, the cut‐off values revealed a sensitivity of 96.8% and a specificity of 90% for indicating trisomies 21, and a sensitivity of 88.9% and a specificity of 92.6% for trisomies 18. However, probably due to the sample size, the sensitivity and specificity for indicating trisomy 13 were lower (85.7% and 61.1%) than that for trisomies 21 and 18. The positive predictive values in pregnancies with positive NIPT results at Z‐score greater than or equal to cut‐off value were 99.18% (121/122) for trisomy 21, 92.31% (24/26) for trisomy 18 and 46.15% (6/13) for trisomy 13. In patients with a Z‐score between 3 and cut‐off Z‐score, the PPV of NIPT for trisomies 21, 18 and 13 were 30.77% (4/13), 10.71% (3/28) and 8.33% (1/12) respectively. Moreover, by classifying Z scores as 3≤Z<5, 5≤Z<10, and Z≥10, the majority of Z scores were above 10 with a PPV of 99% for T21 and just 5.2% were between 3 and 5 with a PPV of 14.3%. In contrast for T18, over a third of tests had Z scores between 3 and 5. The PPV in this group is just over 5%. ConclusionsThe present results show that the PPV performance of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 are closely associated with Z‐score. The higher the Z‐score, the greater the likelihood that the aneuploidy result is correct. Our experience in evaluating the Z‐score accuracy of NIPT in this study could be of use in similar work.This article is protected by copyright. All rights reserved.

Predictive Significance of Risk Value in Prenatal Screening for Fetal Trisomy 18

Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.

Noninvasive Prenatal Testing of Trisomies 21 and 18 by Massively Parallel Sequencing of Maternal Plasma DNA in Twin Pregnancies.

Prenatal Diagnosis for Trisomy 18——analysis of 9 Cases

Diagnostic value of maternal alpha-fetoprotein variants in second-trimester biochemical screening for trisomy 21 and 18

Efficiency of Non-invasive Prenatal Screening in Pregnant Women at Advanced Maternal Age

A Risk Model for Predicting Fetuses with Trisomy 21 Using Alpha-Fetoprotein Variants L2 Combined with Maternal Serum Biomarkers in Early Pregnancy

Evaluation of Maternal Serum sHLA-G Levels for Trisomy 18 Fetuses Screening at Second Trimester

[Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples]

Analysis of Prenatal Serological Screening of 116 Pregnant Women with Trisomy 21 Syndrome Fetus

[Analysis of the results of chromosomal trisomies 21, 18 and 13 screening among 40 628 women by non-invasive prenatal testing]

Maternal Prenatal Screening Programs That Predict Trisomy 21, Trisomy 18, and Neural Tube Defects in Offspring

Detection of Cell-Free Fetal DNA in Maternal Plasma for Noninvasive Prenatal Screening of Fetal Chromosomal Aneuploidies in Women of Advanced Maternal Age

Study on the Clinical Value of Noninvasive Prenatal Testing in Screening the Chromosomal Abnormalities of the Fetus in the Elderly Pregnant Women

Evaluation of the Z‐score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center

Association of maternal risk factors with fetal aneuploidy and the accuracy of prenatal aneuploidy screening: a correlation analysis based on 12,186 karyotype reports

Clinical Efficiency of Non-invasive Prenatal Screening for Common Trisomies in Low-Risk and Twin Pregnancies

Clinical Analysis on Prenatal Diagnosis of Amniocentesis in 818 Cases

The Effect of Non-Invasive Prenatal Testing in Screening Fetal Chromosomal Abnormalities and Its Correlation with Gestational Age and Maternal Age.

A retrospective evaluation of second-trimester serum screening for fetal trisomy 18: experience of two laboratories

Improved contingent screening strategy increased trisomy 21 detection rate in the second trimester